Abell v. Graham

CourtDistrict Court, D. Maryland
DecidedAugust 12, 2020
Docket8:19-cv-02155
StatusUnknown

This text of Abell v. Graham (Abell v. Graham) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Abell v. Graham, (D. Md. 2020).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND

MARTIN CHARLES ABELL, SR., *

Plaintiff *

v * Civil Action No. PX-19-2155

RICHARD J. GRAHAM, JR., Warden, * WEXFORD HEALTH SOURCES, INC., and CORIZON HEALTH, INC., *

Defendants * ***

MEMORANDUM OPINION Martin Charles Abell, Sr. brings this suit pursuant to 42 U.S.C. § 1983 alleging that Defendants Warden Richard J. Graham at Western Correctional Institution (“WCI”), and WCI medical providers Wexford Health Sources, Inc. (“Wexford”) and Corizon Health, Inc. (“Corizon”)1 subjected him to cruel and unusual punishment by providing inadequate medical care. ECF No. 1. Defendants each filed a motion to dismiss or, alternatively, for summary judgment. ECF Nos. 17, 20, 28. Abell responded. ECF No. 30. The matter is now ripe for review, with no need for a hearing. See Loc. R. 105.6. For the reasons that follow, Defendants’ motions, construed as motions for summary judgment, are GRANTED. I. Background Abell is a 67-year-old inmate who has been housed at WCI since August 9, 2013. ECF No. 7-3 at 7. He suffers from hypertension, Type II diabetes, a left eye cataract, cancer, heart disease, an enlarged prostate, high cholesterol, and psoriasis. See generally ECF No. 17-3; ECF

1 The Clerk shall be directed to amend the docket to correct the names of Defendants Wexford and Corizon. No. 17-2. Abell challenges the adequacy of his medical care for many of his ailments. The Court reviews Abell’s course of care for each significant ailment. A. Eye Care & Cancer Treatment On August 13, 2015, Abell was diagnosed with a dense cataract on his left eye. ECF No.

17-3 at 86. On February 9, 2017, he underwent surgery to remove the cataract. Id. at 226; see also Medical Records, CF No. 28-3 at 39. The surgery, however, was not without subsequent complication. Abell developed posterior capsule opacification (“PCO”), a cloudy layer of scar tissue that may form behind the lens of an eye after cataract surgery. ECF No. 17-3 at 143. As of April 2017, Abell had not received a laser procedure that is standard to correct the PCO. Id. At Abell’s next visit with an ophthalmologist on October 12, 2017, the doctor noticed a one-centimeter lesion near Abell’s left eye which the doctor suspected could be cancer. Abell also had an ulcer on his chest which appeared to extend into the bone that the doctor also suspected was cancerous. Id. at 225. The ophthalmologist sought a dermatology consultation and request for a skin biopsy of both sites. Id. at 223. Biopsies confirmed both lesions were cancerous. Id.

at 195, 69. On March 9, 2018, Abell had the lesion on his chest removed successfully, and several months later, the lesion near his eye was also removed. Id. at 215, 202-03. On October 26, 2018, Medical Director Dr. Asresahegn Getachew met with Abell. At that visit, Abell learned that the lesions near his eye and on his chest were healing well, but he now appeared to have new, concerning skin lesions near his naval. Id. at 187. By January 7, 2019, Abell’s skin lesions around his naval were readily apparent. Id. at 168. Dr. Getachew submitted a dermatology consultation request for biopsy and excision which had been performed successfully. Id. By July 23, 2019, Dr. Getachew noted at a follow up telemedicine visit with Abell that his basal cell cancer was in remission. Id. at 116. Two days later, on July 25, 2019, Abell received his laser procedure to correct the PCO. Id. at 196. The procedure went well, and on August 21, 2019, Abell had 20/30 vision in each eye. Id. at 106. B. Diabetes

Abell has suffered from Type II diabetes for 15 years, however his condition grew worse in January 2017. See id. at 208; ECF No. 28-3 at 41-48. In April 2017, Abell experienced a brief period in which his diabetes was considered “uncontrolled.” ECF No. 28-3 at 50-51, 65-70. Abell also appeared not to comply wholly with his insulin regime from September 2017 to January 2018. Id. at 77, 84-89, 99-103. As of a March 28, 2018 telemedicine visit with Dr. Getachew, Abell’s testing indicated poorly controlled diabetes, and so Dr. Getachew planned to monitor Abell’s fasting blood glucose and adjust his insulin as needed. Id. Dr. Getachew next saw Abell a month later. At that time, the record reflects that Abell complained that a certain medication, Metformin, had adverse side effects. Id. at 204-07. Dr. Getachew and Abell discussed a medication plan going forward as well as the importance Abell

maintaining a healthy diet, exercising, and taking his medication as directed. Id. Regrettably, Abell continued to struggle with medication compliance. As of October 26, 2018, his diabetes remained poorly controlled. Id. at 187-91. He was was not reporting to the dispensary for his morning insulin because he did not like the nurse, and so Dr. Getachew assigned him to another nurse. Id. Dr. Getachew also adjusted Abell’s insulin dose and scheduled follow up testing and a visit with an experienced nurse educator. Id. In the months that followed, as Abell still struggled with noncompliance, Dr. Getachew responded by readjusting Abell’s medication and providing further patient education. Id. at 170- 73, 181. Abell refused his medication for several days out of each month. Id. at 156-167; Id. at 4-33, 123-24; 116-19. By July 31, 2019, Abell’s blood sugar dangerously high. Id. at 112-15. Several days later, while at the infirmary, Abell acknowledged that he had not been compliant with diet or exercise recommendations. Id. at 109-11. Although nursing staff continued to encourage Abell to test his blood sugar as directed and take his medication, he subsequently refused on

August 21 and 24, 2019. Id. at 2, 105. On August 26, 2019, Abell again visited the infirmary with dangerously elevated glucose. Id. at 103-04. He complained that the insulin had been causing him pain in his sides and that he was urinating frequently. Id. A nurse explained to him that this was his body’s reaction to the excess sugar. Id. He again reported to the infirmary the next day. His glucose remained high despite being on IV insulin. Id. at 101-02. At that visit, the nurse learned that Abell was carrying sugar packets, jams, and fruits with him and confiscated the sugary items. Id. Dr. Getachew admitted Abell to the infirmary and prescribed Metformin. Id. On September 5, 2019, the medical team recommended a psychiatric consultation to address Abell’s noncompliance with his insulin therapy. Id. at 96-98. At Abell’s scheduled visit

with nurse practitioner Janette Clark on September 28, 2019, Abell shared he was convinced that someone had tampered with his insulin bottles. Id. at 90-92. Abell asked for, and received, long- acting insulin and that the nursing staff retain the insulin bottles. Id. A follow up administrative note entered on October 3, 2019, reflects subsequent team conference with medical and mental health providers, the agency contract monitor, and clinical pharmacists to review Abell’s diabetic care. Id. at 88-89. Abell and the team agreed to a medication and monitoring plan. Id. C. Additional Conditions & Need for Wheelchair During Abell’s telemedicine visit with Dr. Getachew on March 28, 2018, Abell shared that he suffered with shortness of breath on mild exertion, which necessitated that he use a wheelchair instead of walking long distances. Id. at 208-10. Upon review of Abell’s medical history, significant for prior coronary bypass procedure, Dr. Getachew surmised that Abell may be suffering from uncontrolled coronary artery disease. Dr. Getachew submitted a request for a cardiology consultation. Id.

Abell saw a cardiologist via telemedicine on May 21, 2018. Id. at 213-14.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United Mine Workers of America v. Gibbs
383 U.S. 715 (Supreme Court, 1966)
Gregg v. Georgia
428 U.S. 153 (Supreme Court, 1976)
Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Carnegie-Mellon University v. Cohill
484 U.S. 343 (Supreme Court, 1988)
Munaf v. Geren
553 U.S. 674 (Supreme Court, 2008)
Gallagher v. Shelton
587 F.3d 1063 (Tenth Circuit, 2009)
In Re Family Dollar FLSA Litigation
637 F.3d 508 (Fourth Circuit, 2011)
United States v. Clawson
650 F.3d 530 (Fourth Circuit, 2011)
Llewellyn Culbert v. Warren Young
834 F.2d 624 (Seventh Circuit, 1987)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Roberts v. SUBURBAN HOSPITAL ASS'N, INC.
532 A.2d 1081 (Court of Special Appeals of Maryland, 1987)

Cite This Page — Counsel Stack

Bluebook (online)
Abell v. Graham, Counsel Stack Legal Research, https://law.counselstack.com/opinion/abell-v-graham-mdd-2020.